Lobbying Filing Details
Total Spending
$340,000
Activities
4
Lobbyists
3
Gov't Entities
8
Filing Information
- Filing UUID:
69a4e35d-c015-4745-8409-6ee19794b0c6- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2026 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 20, 2026 at 8:24 PM
- Income:
- $0
- Expenses:
- $340,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Jason D. Kaune, Attorney & Agent for Filer
Registrant
BIOMARIN PHARMACEUTICAL INC.
Develops and commercializes biopharmaceuticals.
San Rafael, CaliforniaClient
BIOMARIN PHARMACEUTICAL INC.
California, United States of AmericaLobbying Activities (4)
Activity 1
Health IssuesGENERAL DISCUSSIONS REGARDING MEDICAID GENERAL DISCUSSIONS REGARDING NEWBORN SCREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS REGARDING PATIENT EXPERIENCE DATA GENERAL DISCUSSIONS REGARDING RECOMMENDED UNIFORM SCREENING PANEL (RUSP) CONDITION ADDITION GENERAL DISCUSSIONS REGARDING GENETIC SCREENING AND TESTING
Lobbyists (3)
- KATHRYN LOWELL
- JOHN EDWARD GREISSING
- DANIEL MAYNE
Government Entities (4)
- SENATE
- HOUSE OF REPRESENTATIVES
- Health & Human Services, Dept of (HHS)
- Health Resources & Services Administration (HRSA)
Activity 2
Medical/Disease Research/Clinical LabsGENERAL DISCUSSIONS REGARDING CLINICAL TRIAL MODERNIZATION
Lobbyists (1)
- DANIEL MAYNE
Government Entities (1)
- HOUSE OF REPRESENTATIVES
Activity 3
Medicare/MedicaidGENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) FOREIGN REFERENCE PRICING GENERAL DISCUSSIONS REGARDING MEDICAID PRIOR AUTHORIZATION GENERAL DISCUSSIONS REGARDING UTILIZATION MANAGEMENT
Lobbyists (3)
- KATHRYN LOWELL
- JOHN EDWARD GREISSING
- DANIEL MAYNE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 4
Tariff (miscellaneous tariff bills)GENERAL DISCUSSIONS REGARDING TARDE
Lobbyists (1)
- KATHRYN LOWELL
Government Entities (1)
- HOUSE OF REPRESENTATIVES